Histological features Classification Description Frequencies, n (%)
Necroses 0) None
1) Small
2) Large
3) Large and small
Areas with necrotic morphology 0) 3/200 (1.5 %)
1) 34/200 (17.0 %)
2) 56/200 (28.0 %)
3) 107/200 (53.5 %)
Apoptoses   Apoptotic figures  200/200 (100.0 %)
Mitoses Number of mitotic figures in 10 consecutive high power fields (HPFs) Counted in the most proliferative active areas with the 40x objective (HPF) Median: 8.5
Mean: 12.8
Range: 0 – 64
≥1 mitosis: 192/200 (96 %)
None: 8/200 (4.0 %)
Microvascular proliferation 1) Glomeruloid tufts
2) Endothelial proliferation
3) Both
4) None
Present or not present, in the tumour centre and the infiltrating front 1)130/200 (65.0 %)
2) 164/200 (82.0 %)
3) 136/200 (63.0 %)
4) 31/200 (15.5 %)
Cell types 1) Gemistocytes
2) Small cells
3) Spindle cells
4) Epitheloid cells
When present in more than 20% of the tumour 1) 67/200 (33.5 %)
2) 42/200 (21.0 %)
3) 19/200 (9.5 %)
5) 4/200 (2.0 %)
Subtypes 1) Small cell glioblastoma
2) Giant cell glioblastoma
3) Gliosarcoma
Tumours consisting predominantly of one cell type 1) 14/200 (7.0 %)
2) 2/200 (1.0 %)
3) 0/200 (0.0 %)
Giant cells 0) None
1) Sparsely
2) Moderate
3) Common
Large, often multinucleated, highly atypical cells 0) 112/200 = (56.0 %)
1) 53/200 = (26.5 %)
2) 27/200 = (13.5 %)
3) 8/200 = (4.0 %)
Oligodendroglioma component 0) None
1) Present in < 20 %
2) Present in > 20 %.
Areas of oligodendroglioma-like morphology 0)187/200 (93.5 %)
1) 8/200 (4.0 %)
2) 5/200 (2.5 %)
Perivascular lymphocyte infiltration     73/200 (36.5 %)
Macrophage infiltration     52/200 (26.0 %)
Haemorrhages   Blood degradation or haemosiderine-laden macrophages 106/200 (53.0 %)
Thromboses   Thrombotic occluded vessels 157/200 (78.5 %)
Calcification     24/200 (12.0 %)
Pseudopalisades     158/200 (79.0 %)
Atypia 1) Mild
2) Moderate
3) Severe
  1) 15/200 (7.5 %)
2) 134/200 (67.0 %)
3) 51/200 (25.5 %)
Cell density 1) Low
2) Moderate
3) High
  1) 7/200 (3.5 %)
2)141/200 (70.5 %)
3) 52/200 (26.0 %)
Pseudorosettes     93/200 (46.5 %)
Desmoplasia     88/200 (44.0 %)
Nucleoli     23/200 (11.5 %)
Atypical mitoses     119/200 (59.5 %)
Microcysts     58/200 (29.0 %)
Mucin     66/200 (33.0 %)
Leptomeningeal infiltration     45/200 (22.5 %)
Secondary structures of Scherer 1) Perineural growth
2) Angiocentric growth
3) Subpial cell-clustering  4)One or more phenomena
Assessment of Scherer phenomena was possible in 147 and 127 cases, respectively 1) 52/147 (34.5 %)
2) 40/147 (27.2 %)
3) 20/124 (16.1 %) 4) 73/152 (48.0 %)
Table 1: Histopathological characteristics in 200 primary glioblastomas.